Sales Support
U.S.:+1-415-871-0703
U.K.:+44-203-289-4040
AUS.: +61-2-4786-0457
INDIA:+91-848-285-0837
Contact Us
We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
Healthcare and Pharmaceuticals industry

Postmenopausal Vaginal Atrophy Drugs Market 2020 By Manufacturers, Regions, Type, And Application, Forecast To 2026

  • Purchase Options

 

Summary

The global Postmenopausal Vaginal Atrophy Drugs Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019. 

Postmenopausal vaginal atrophy is a medical condition that is characterized by the reduction of estrogen production after menopause. A low level of estrogen leads to thinning and decreases in the elasticity of the vaginal tissues. Itching, dyspareunia, redness, and irritation are some of the symptoms of vaginal atrophy. Vaginal atrophy can be diagnosed by using tests such as vaginal smear test, pelvic examination, blood test, vaginal activity test, and urine test. This can be treated by using vaginal gels, creams, and patches therapies.

The rising prevalence of postmenopausal vaginal atrophy is primarily fueling market growth. The advent of novel therapies with improved efficacy is expected to augment the market growth of postmenopausal vaginal atrophy drugs. For instance, in September 2018, TherapeuticsMD, Inc. an women’s healthcare company, announced the commercial availability of Imvexxy™ (estradiol vaginal inserts) 4 mcg dose in the United States. Moreover, favorable healthcare reforms coupled with the growing R &D in the field are expected to offer enormous market opportunities in the near future. On the other hand, a low diagnosis rate is a major factor expected to hinder the market growth of postmenopausal vaginal atrophy drugs.

North America is expected to gain significant growth over the forecast period and this is attributed to a high level of awareness regarding this medical condition among women coupled with the favorable reimbursement policies in the region. Moreover, the presence of a well-established pharmaceutical industry in the region is further expected to fuel the market growth of postmenopausal vaginal atrophy drugs. According to the IQVIA Institute for Human Data Science, in 2018 the spending on the pharmaceutical industry was $485 billion, up 5.2% from 2017, and the spending will increase to $625-655 billion by 2023, representing a 4-7% CAGR over the five-year period.

Key Developments:

In October 2018, TherapeuticsMD, Inc. announced that the United States Food and Drug Administration (FDA) has approved BIJUVA™ (estradiol and progesterone) capsules, 1 mg/100 mg, the first and only FDA-approved bio-identical* hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate to severe vasomotor symptoms due to menopause in women with a uterus.

The Postmenopausal Vaginal Atrophy Drugs Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Postmenopausal Vaginal Atrophy Drugs Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.

The Key Manufacturers covered in this Report:-

  • Actavis plc
  • Bionovo, Inc.
  • Endoceutics, Inc.
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Teva Pharmaceuticals Ltd.
  • Therapeutics MD, Inc.
  • Shionogi & Company
  • Allergan plc
  • Shionogi & Co. Ltd.

By Product Type, the market is primarily segmented into:

  • Premarin
  • Vagifem
  • Estrace
  • Estring
  • Femring

By Applications, the market is segmented into:

  • Vaginal Gels
  • Creams
  • Tablets
  • Rings
  • Patches

The report covers the following Regions:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Philippines
    • Vietnam
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Central & South America
    • Brazil
  • Middle East & Africa
    • Turkey
    • GCC Countries
    • Egypt
    • South Africa

Objective of the Postmenopausal Vaginal Atrophy Drugs Market Report:

  • To assess the size of the market by value and volume
  • Analyze the Postmenopausal Vaginal Atrophy Drugs Market in terms of regions and major countries
  • Highlight recent developments and trends in the market
  • Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
  • Determine share of the Postmenopausal Vaginal Atrophy Drugs Market in terms of various segments such as by product type, application, and end-user
  • Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
  • Discuss major factors that impact growth of the Postmenopausal Vaginal Atrophy Drugs Market

The Postmenopausal Vaginal Atrophy Drugs Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Postmenopausal Vaginal Atrophy Drugs Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders:

  • Material suppliers/wholesalers
  • Market Distributors/traders
  • Regulatory bodies
  • Research organizations, and consulting firms
  • Commercial research & developments (R&D)
  • Trade associations and industry bodies
  • Importers and exporters
  • End-use industries

Available Customizations:

Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Table of Contents

Executive Summary
1 Postmenopausal Vaginal Atrophy Drugs Market Overview
1.1 Product Overview and Scope of Postmenopausal Vaginal Atrophy Drugs
1.2 Postmenopausal Vaginal Atrophy Drugs Segment by Type
1.2.1 Global Postmenopausal Vaginal Atrophy Drugs Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Premarin
1.2.3 Vagifem
1.2.4 Estrace
1.2.5 Estring
1.2.6 Femring
1.3 Postmenopausal Vaginal Atrophy Drugs Segment by Application
1.3.1 Postmenopausal Vaginal Atrophy Drugs Consumption Comparison by Application (2014-2025)
1.3.2 Vaginal Gels
1.3.3 Creams
1.3.4 Tablets
1.3.5 Rings
1.3.6 Patches
1.4 Global Postmenopausal Vaginal Atrophy Drugs Market by Region
1.4.1 Global Postmenopausal Vaginal Atrophy Drugs Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Postmenopausal Vaginal Atrophy Drugs Market Size
1.5.1 Global Postmenopausal Vaginal Atrophy Drugs Revenue (2014-2025)
1.5.2 Global Postmenopausal Vaginal Atrophy Drugs Production (2014-2025)

2 Global Postmenopausal Vaginal Atrophy Drugs Market Competition by Manufacturers
2.1 Global Postmenopausal Vaginal Atrophy Drugs Production Market Share by Manufacturers (2014-2019)
2.2 Global Postmenopausal Vaginal Atrophy Drugs Revenue Share by Manufacturers (2014-2019)
2.3 Global Postmenopausal Vaginal Atrophy Drugs Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Postmenopausal Vaginal Atrophy Drugs Production Sites, Area Served, Product Types
2.5 Postmenopausal Vaginal Atrophy Drugs Market Competitive Situation and Trends
2.5.1 Postmenopausal Vaginal Atrophy Drugs Market Concentration Rate
2.5.2 Postmenopausal Vaginal Atrophy Drugs Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Postmenopausal Vaginal Atrophy Drugs Production Market Share by Regions
3.1 Global Postmenopausal Vaginal Atrophy Drugs Production Market Share by Regions
3.2 Global Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Regions (2014-2019)
3.3 Global Postmenopausal Vaginal Atrophy Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Postmenopausal Vaginal Atrophy Drugs Production
3.4.1 North America Postmenopausal Vaginal Atrophy Drugs Production Growth Rate (2014-2019)
3.4.2 North America Postmenopausal Vaginal Atrophy Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Postmenopausal Vaginal Atrophy Drugs Production
3.5.1 Europe Postmenopausal Vaginal Atrophy Drugs Production Growth Rate (2014-2019)
3.5.2 Europe Postmenopausal Vaginal Atrophy Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Postmenopausal Vaginal Atrophy Drugs Production
3.6.1 China Postmenopausal Vaginal Atrophy Drugs Production Growth Rate (2014-2019)
3.6.2 China Postmenopausal Vaginal Atrophy Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Postmenopausal Vaginal Atrophy Drugs Production
3.7.1 Japan Postmenopausal Vaginal Atrophy Drugs Production Growth Rate (2014-2019)
3.7.2 Japan Postmenopausal Vaginal Atrophy Drugs Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Postmenopausal Vaginal Atrophy Drugs Consumption by Regions
4.1 Global Postmenopausal Vaginal Atrophy Drugs Consumption by Regions
4.2 North America Postmenopausal Vaginal Atrophy Drugs Consumption (2014-2019)
4.3 Europe Postmenopausal Vaginal Atrophy Drugs Consumption (2014-2019)
4.4 China Postmenopausal Vaginal Atrophy Drugs Consumption (2014-2019)
4.5 Japan Postmenopausal Vaginal Atrophy Drugs Consumption (2014-2019)

5 Global Postmenopausal Vaginal Atrophy Drugs Production, Revenue, Price Trend by Type
5.1 Global Postmenopausal Vaginal Atrophy Drugs Production Market Share by Type (2014-2019)
5.2 Global Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Type (2014-2019)
5.3 Global Postmenopausal Vaginal Atrophy Drugs Price by Type (2014-2019)
5.4 Global Postmenopausal Vaginal Atrophy Drugs Production Growth by Type (2014-2019)

6 Global Postmenopausal Vaginal Atrophy Drugs Market Analysis by Applications
6.1 Global Postmenopausal Vaginal Atrophy Drugs Consumption Market Share by Application (2014-2019)
6.2 Global Postmenopausal Vaginal Atrophy Drugs Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Postmenopausal Vaginal Atrophy Drugs Business
7.1 Actavis plc
7.1.1 Actavis plc Postmenopausal Vaginal Atrophy Drugs Production Sites and Area Served
7.1.2 Postmenopausal Vaginal Atrophy Drugs Product Introduction, Application and Specification
7.1.3 Actavis plc Postmenopausal Vaginal Atrophy Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Bionovo, Inc.
7.2.1 Bionovo, Inc. Postmenopausal Vaginal Atrophy Drugs Production Sites and Area Served
7.2.2 Postmenopausal Vaginal Atrophy Drugs Product Introduction, Application and Specification
7.2.3 Bionovo, Inc. Postmenopausal Vaginal Atrophy Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 Endoceutics, Inc.
7.3.1 Endoceutics, Inc. Postmenopausal Vaginal Atrophy Drugs Production Sites and Area Served
7.3.2 Postmenopausal Vaginal Atrophy Drugs Product Introduction, Application and Specification
7.3.3 Endoceutics, Inc. Postmenopausal Vaginal Atrophy Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 Novo Nordisk A/S
7.4.1 Novo Nordisk A/S Postmenopausal Vaginal Atrophy Drugs Production Sites and Area Served
7.4.2 Postmenopausal Vaginal Atrophy Drugs Product Introduction, Application and Specification
7.4.3 Novo Nordisk A/S Postmenopausal Vaginal Atrophy Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 Pfizer Inc.
7.5.1 Pfizer Inc. Postmenopausal Vaginal Atrophy Drugs Production Sites and Area Served
7.5.2 Postmenopausal Vaginal Atrophy Drugs Product Introduction, Application and Specification
7.5.3 Pfizer Inc. Postmenopausal Vaginal Atrophy Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 Teva Pharmaceuticals Ltd.
7.6.1 Teva Pharmaceuticals Ltd. Postmenopausal Vaginal Atrophy Drugs Production Sites and Area Served
7.6.2 Postmenopausal Vaginal Atrophy Drugs Product Introduction, Application and Specification
7.6.3 Teva Pharmaceuticals Ltd. Postmenopausal Vaginal Atrophy Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served
7.7 Therapeutics MD, Inc.
7.7.1 Therapeutics MD, Inc. Postmenopausal Vaginal Atrophy Drugs Production Sites and Area Served
7.7.2 Postmenopausal Vaginal Atrophy Drugs Product Introduction, Application and Specification
7.7.3 Therapeutics MD, Inc. Postmenopausal Vaginal Atrophy Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.8 Shionogi & Company
7.8.1 Shionogi & Company Postmenopausal Vaginal Atrophy Drugs Production Sites and Area Served
7.8.2 Postmenopausal Vaginal Atrophy Drugs Product Introduction, Application and Specification
7.8.3 Shionogi & Company Postmenopausal Vaginal Atrophy Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.8.4 Main Business and Markets Served
7.9 Allergan plc
7.9.1 Allergan plc Postmenopausal Vaginal Atrophy Drugs Production Sites and Area Served
7.9.2 Postmenopausal Vaginal Atrophy Drugs Product Introduction, Application and Specification
7.9.3 Allergan plc Postmenopausal Vaginal Atrophy Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.9.4 Main Business and Markets Served
7.10 Shionogi & Co. Ltd.
7.10.1 Shionogi & Co. Ltd. Postmenopausal Vaginal Atrophy Drugs Production Sites and Area Served
7.10.2 Postmenopausal Vaginal Atrophy Drugs Product Introduction, Application and Specification
7.10.3 Shionogi & Co. Ltd. Postmenopausal Vaginal Atrophy Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.10.4 Main Business and Markets Served

8 Postmenopausal Vaginal Atrophy Drugs Manufacturing Cost Analysis
8.1 Postmenopausal Vaginal Atrophy Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Postmenopausal Vaginal Atrophy Drugs
8.4 Postmenopausal Vaginal Atrophy Drugs Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Postmenopausal Vaginal Atrophy Drugs Distributors List
9.3 Postmenopausal Vaginal Atrophy Drugs Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global Postmenopausal Vaginal Atrophy Drugs Market Forecast
11.1 Global Postmenopausal Vaginal Atrophy Drugs Production, Revenue Forecast
11.1.1 Global Postmenopausal Vaginal Atrophy Drugs Production Growth Rate Forecast (2019-2025)
11.1.2 Global Postmenopausal Vaginal Atrophy Drugs Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Postmenopausal Vaginal Atrophy Drugs Price and Trend Forecast (2019-2025)
11.2 Global Postmenopausal Vaginal Atrophy Drugs Production Forecast by Regions (2019-2025)
11.2.1 North America Postmenopausal Vaginal Atrophy Drugs Production, Revenue Forecast (2019-2025)
11.2.2 Europe Postmenopausal Vaginal Atrophy Drugs Production, Revenue Forecast (2019-2025)
11.2.3 China Postmenopausal Vaginal Atrophy Drugs Production, Revenue Forecast (2019-2025)
11.2.4 Japan Postmenopausal Vaginal Atrophy Drugs Production, Revenue Forecast (2019-2025)
11.3 Global Postmenopausal Vaginal Atrophy Drugs Consumption Forecast by Regions (2019-2025)
11.3.1 North America Postmenopausal Vaginal Atrophy Drugs Consumption Forecast (2019-2025)
11.3.2 Europe Postmenopausal Vaginal Atrophy Drugs Consumption Forecast (2019-2025)
11.3.3 China Postmenopausal Vaginal Atrophy Drugs Consumption Forecast (2019-2025)
11.3.4 Japan Postmenopausal Vaginal Atrophy Drugs Consumption Forecast (2019-2025)
11.4 Global Postmenopausal Vaginal Atrophy Drugs Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Postmenopausal Vaginal Atrophy Drugs Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Table
List of Tables and Figures

Figure Picture of Postmenopausal Vaginal Atrophy Drugs
Table Global Postmenopausal Vaginal Atrophy Drugs Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Postmenopausal Vaginal Atrophy Drugs Production Market Share by Types in 2018
Figure Premarin Product Picture
Table Premarin Major Manufacturers
Figure Vagifem Product Picture
Table Vagifem Major Manufacturers
Figure Estrace Product Picture
Table Estrace Major Manufacturers
Figure Estring Product Picture
Table Estring Major Manufacturers
Figure Femring Product Picture
Table Femring Major Manufacturers
Table Global Postmenopausal Vaginal Atrophy Drugs Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Postmenopausal Vaginal Atrophy Drugs Consumption Market Share by Applications in 2018
Figure Vaginal Gels
Figure Creams
Figure Tablets
Figure Rings
Figure Patches
Table Postmenopausal Vaginal Atrophy Drugs Market Size (Million US$) Comparison by Regions (2014-2025)
Figure North America Postmenopausal Vaginal Atrophy Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Europe Postmenopausal Vaginal Atrophy Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure China Postmenopausal Vaginal Atrophy Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan Postmenopausal Vaginal Atrophy Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Global Postmenopausal Vaginal Atrophy Drugs Revenue (Million USD) (2014-2025)
Figure Global Postmenopausal Vaginal Atrophy Drugs Production (K Units) (2014-2025)
Table Global Postmenopausal Vaginal Atrophy Drugs Production (K Units) of Key Manufacturers (2014-2019)
Table Global Postmenopausal Vaginal Atrophy Drugs Production Share by Manufacturers (2014-2019)
Figure Postmenopausal Vaginal Atrophy Drugs Production Share by Manufacturers in 2018
Table Global Postmenopausal Vaginal Atrophy Drugs Revenue (Million USD) by Manufacturers (2014-2019)
Table Global Postmenopausal Vaginal Atrophy Drugs Revenue Share by Manufacturers (2014-2019)
Figure Global Postmenopausal Vaginal Atrophy Drugs Revenue Share by Manufacturers in 2018
Table Global Market Postmenopausal Vaginal Atrophy Drugs Average Price (USD/Unit) of Key Manufacturers (2014-2019)
Figure Global Market Postmenopausal Vaginal Atrophy Drugs Average Price (USD/Unit) of Key Manufacturers in 2018
Table Manufacturers Postmenopausal Vaginal Atrophy Drugs Production Sites and Area Served
Table Manufacturers Postmenopausal Vaginal Atrophy Drugs Product Types
Figure Postmenopausal Vaginal Atrophy Drugs Market Share of Top 5 Manufacturers
Figure Postmenopausal Vaginal Atrophy Drugs Market Share of Top 10 Manufacturers
Table Global Postmenopausal Vaginal Atrophy Drugs Production (K Units) by Region (2014-2019)
Table Global Postmenopausal Vaginal Atrophy Drugs Production Market Share by Region (2014-2019)
Figure Global Postmenopausal Vaginal Atrophy Drugs Production Market Share by Region (2014-2019)
Figure Global Postmenopausal Vaginal Atrophy Drugs Production Market Share by Region in 2018
Table Global Postmenopausal Vaginal Atrophy Drugs Revenue (Million USD) by Region (2014-2019)
Table Global Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Region (2014-2019)
Figure Global Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Region (2014-2019)
Figure Global Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Region in 2018
Figure Global Postmenopausal Vaginal Atrophy Drugs Production (K Units) Growth Rate (2014-2019)
Table Global Postmenopausal Vaginal Atrophy Drugs Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Figure North America Postmenopausal Vaginal Atrophy Drugs Production (K Units) Growth Rate (2014-2019)
Table North America Postmenopausal Vaginal Atrophy Drugs Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Europe Postmenopausal Vaginal Atrophy Drugs Production (K Units) Growth Rate (2014-2019)
Table Europe Postmenopausal Vaginal Atrophy Drugs Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure China Postmenopausal Vaginal Atrophy Drugs Production (K Units) Growth Rate (2014-2019)
Table China Postmenopausal Vaginal Atrophy Drugs Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Japan Postmenopausal Vaginal Atrophy Drugs Production (K Units) Growth Rate (2014-2019)
Table Japan Postmenopausal Vaginal Atrophy Drugs Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Global Postmenopausal Vaginal Atrophy Drugs Consumption (K Units) Market by Region (2014-2019)
Table Global Postmenopausal Vaginal Atrophy Drugs Consumption Market Share by Region (2014-2019)
Figure Global Postmenopausal Vaginal Atrophy Drugs Consumption Market Share by Region (2014-2019)
Figure Global Postmenopausal Vaginal Atrophy Drugs Consumption Market Share by Region in 2018
Figure North America Postmenopausal Vaginal Atrophy Drugs Consumption Growth Rate (2014-2019) (K Units)
Figure Europe Postmenopausal Vaginal Atrophy Drugs Consumption Growth Rate (2014-2019) (K Units)
Figure China Postmenopausal Vaginal Atrophy Drugs Consumption Growth Rate (2014-2019) (K Units)
Figure Japan Postmenopausal Vaginal Atrophy Drugs Consumption Growth Rate (2014-2019) (K Units)
Table Global Postmenopausal Vaginal Atrophy Drugs Production (K Units) by Type (2014-2019)
Table Global Postmenopausal Vaginal Atrophy Drugs Production Share by Type (2014-2019)
Figure Production Market Share of Postmenopausal Vaginal Atrophy Drugs by Type (2014-2019)
Figure Production Market Share of Postmenopausal Vaginal Atrophy Drugs by Type in 2018
Table Global Postmenopausal Vaginal Atrophy Drugs Revenue (Million USD) by Type (2014-2019)
Table Global Postmenopausal Vaginal Atrophy Drugs Revenue Share by Type (2014-2019)
Figure Revenue Share of Postmenopausal Vaginal Atrophy Drugs by Type (2014-2019)
Figure Revenue Market Share of Postmenopausal Vaginal Atrophy Drugs by Type in 2018
Table Global Postmenopausal Vaginal Atrophy Drugs Price (USD/Unit) by Type (2014-2019)
Figure Global Postmenopausal Vaginal Atrophy Drugs Production Growth by Type (2014-2019) (K Units)
Table Global Postmenopausal Vaginal Atrophy Drugs Consumption (K Units) by Application (2014-2019)
Table Global Postmenopausal Vaginal Atrophy Drugs Consumption Market Share by Application (2014-2019)
Figure Global Postmenopausal Vaginal Atrophy Drugs Consumption Market Share by Applications (2014-2019)
Figure Global Postmenopausal Vaginal Atrophy Drugs Consumption Market Share by Application in 2018
Table Global Postmenopausal Vaginal Atrophy Drugs Consumption Growth Rate by Application (2014-2019)
Figure Global Postmenopausal Vaginal Atrophy Drugs Consumption Growth Rate by Application (2014-2019)
Table Actavis plc Postmenopausal Vaginal Atrophy Drugs Production Sites and Area Served
Table Actavis plc Product Introduction, Application and Specification
Table Actavis plc Postmenopausal Vaginal Atrophy Drugs Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Actavis plc Postmenopausal Vaginal Atrophy Drugs Production Growth Rate (2014-2019)
Figure Actavis plc Postmenopausal Vaginal Atrophy Drugs Production Market Share (2014-2019)
Figure Actavis plc Postmenopausal Vaginal Atrophy Drugs Revenue Market Share (2014-2019)
Table Actavis plc Main Business and Markets Served
Table Bionovo, Inc. Postmenopausal Vaginal Atrophy Drugs Production Sites and Area Served
Table Bionovo, Inc. Product Introduction, Application and Specification
Table Bionovo, Inc. Postmenopausal Vaginal Atrophy Drugs Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Bionovo, Inc. Postmenopausal Vaginal Atrophy Drugs Production Growth Rate (2014-2019)
Figure Bionovo, Inc. Postmenopausal Vaginal Atrophy Drugs Production Market Share (2014-2019)
Figure Bionovo, Inc. Postmenopausal Vaginal Atrophy Drugs Revenue Market Share (2014-2019)
Table Bionovo, Inc. Main Business and Markets Served
Table Endoceutics, Inc. Postmenopausal Vaginal Atrophy Drugs Production Sites and Area Served
Table Endoceutics, Inc. Product Introduction, Application and Specification
Table Endoceutics, Inc. Postmenopausal Vaginal Atrophy Drugs Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Endoceutics, Inc. Postmenopausal Vaginal Atrophy Drugs Production Growth Rate (2014-2019)
Figure Endoceutics, Inc. Postmenopausal Vaginal Atrophy Drugs Production Market Share (2014-2019)
Figure Endoceutics, Inc. Postmenopausal Vaginal Atrophy Drugs Revenue Market Share (2014-2019)
Table Endoceutics, Inc. Main Business and Markets Served
Table Novo Nordisk A/S Postmenopausal Vaginal Atrophy Drugs Production Sites and Area Served
Table Novo Nordisk A/S Product Introduction, Application and Specification
Table Novo Nordisk A/S Postmenopausal Vaginal Atrophy Drugs Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Novo Nordisk A/S Postmenopausal Vaginal Atrophy Drugs Production Growth Rate (2014-2019)
Figure Novo Nordisk A/S Postmenopausal Vaginal Atrophy Drugs Production Market Share (2014-2019)
Figure Novo Nordisk A/S Postmenopausal Vaginal Atrophy Drugs Revenue Market Share (2014-2019)
Table Novo Nordisk A/S Main Business and Markets Served
Table Pfizer Inc. Postmenopausal Vaginal Atrophy Drugs Production Sites and Area Served
Table Pfizer Inc. Product Introduction, Application and Specification
Table Pfizer Inc. Postmenopausal Vaginal Atrophy Drugs Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Pfizer Inc. Postmenopausal Vaginal Atrophy Drugs Production Growth Rate (2014-2019)
Figure Pfizer Inc. Postmenopausal Vaginal Atrophy Drugs Production Market Share (2014-2019)
Figure Pfizer Inc. Postmenopausal Vaginal Atrophy Drugs Revenue Market Share (2014-2019)
Table Pfizer Inc. Main Business and Markets Served
Table Teva Pharmaceuticals Ltd. Postmenopausal Vaginal Atrophy Drugs Production Sites and Area Served
Table Teva Pharmaceuticals Ltd. Product Introduction, Application and Specification
Table Teva Pharmaceuticals Ltd. Postmenopausal Vaginal Atrophy Drugs Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Teva Pharmaceuticals Ltd. Postmenopausal Vaginal Atrophy Drugs Production Growth Rate (2014-2019)
Figure Teva Pharmaceuticals Ltd. Postmenopausal Vaginal Atrophy Drugs Production Market Share (2014-2019)
Figure Teva Pharmaceuticals Ltd. Postmenopausal Vaginal Atrophy Drugs Revenue Market Share (2014-2019)
Table Teva Pharmaceuticals Ltd. Main Business and Markets Served
Table Therapeutics MD, Inc. Postmenopausal Vaginal Atrophy Drugs Production Sites and Area Served
Table Therapeutics MD, Inc. Product Introduction, Application and Specification
Table Therapeutics MD, Inc. Postmenopausal Vaginal Atrophy Drugs Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Therapeutics MD, Inc. Postmenopausal Vaginal Atrophy Drugs Production Growth Rate (2014-2019)
Figure Therapeutics MD, Inc. Postmenopausal Vaginal Atrophy Drugs Production Market Share (2014-2019)
Figure Therapeutics MD, Inc. Postmenopausal Vaginal Atrophy Drugs Revenue Market Share (2014-2019)
Table Therapeutics MD, Inc. Main Business and Markets Served
Table Shionogi & Company Postmenopausal Vaginal Atrophy Drugs Production Sites and Area Served
Table Shionogi & Company Product Introduction, Application and Specification
Table Shionogi & Company Postmenopausal Vaginal Atrophy Drugs Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Shionogi & Company Postmenopausal Vaginal Atrophy Drugs Production Growth Rate (2014-2019)
Figure Shionogi & Company Postmenopausal Vaginal Atrophy Drugs Production Market Share (2014-2019)
Figure Shionogi & Company Postmenopausal Vaginal Atrophy Drugs Revenue Market Share (2014-2019)
Table Shionogi & Company Main Business and Markets Served
Table Allergan plc Postmenopausal Vaginal Atrophy Drugs Production Sites and Area Served
Table Allergan plc Product Introduction, Application and Specification
Table Allergan plc Postmenopausal Vaginal Atrophy Drugs Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Allergan plc Postmenopausal Vaginal Atrophy Drugs Production Growth Rate (2014-2019)
Figure Allergan plc Postmenopausal Vaginal Atrophy Drugs Production Market Share (2014-2019)
Figure Allergan plc Postmenopausal Vaginal Atrophy Drugs Revenue Market Share (2014-2019)
Table Allergan plc Main Business and Markets Served
Table Shionogi & Co. Ltd. Postmenopausal Vaginal Atrophy Drugs Production Sites and Area Served
Table Shionogi & Co. Ltd. Product Introduction, Application and Specification
Table Shionogi & Co. Ltd. Postmenopausal Vaginal Atrophy Drugs Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Shionogi & Co. Ltd. Postmenopausal Vaginal Atrophy Drugs Production Growth Rate (2014-2019)
Figure Shionogi & Co. Ltd. Postmenopausal Vaginal Atrophy Drugs Production Market Share (2014-2019)
Figure Shionogi & Co. Ltd. Postmenopausal Vaginal Atrophy Drugs Revenue Market Share (2014-2019)
Table Shionogi & Co. Ltd. Main Business and Markets Served
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Postmenopausal Vaginal Atrophy Drugs
Figure Manufacturing Process Analysis of Postmenopausal Vaginal Atrophy Drugs
Figure Postmenopausal Vaginal Atrophy Drugs Industrial Chain Analysis
Table Postmenopausal Vaginal Atrophy Drugs Distributors List
Table Postmenopausal Vaginal Atrophy Drugs Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Figure Global Postmenopausal Vaginal Atrophy Drugs Production (K Units) and Growth Rate Forecast (2019-2025)
Figure Global Postmenopausal Vaginal Atrophy Drugs Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Global Postmenopausal Vaginal Atrophy Drugs Price and Trend Forecast (2019-2025)
Table Global Postmenopausal Vaginal Atrophy Drugs Production (K Units) Forecast by Region (2019-2025)
Figure Global Postmenopausal Vaginal Atrophy Drugs Production Market Share Forecast by Region (2019-2025)
Figure North America Postmenopausal Vaginal Atrophy Drugs Production (K Units) and Growth Rate Forecast (2019-2025)
Figure North America Postmenopausal Vaginal Atrophy Drugs Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Europe Postmenopausal Vaginal Atrophy Drugs Production (K Units) and Growth Rate Forecast (2019-2025)
Figure Europe Postmenopausal Vaginal Atrophy Drugs Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure China Postmenopausal Vaginal Atrophy Drugs Production (K Units) and Growth Rate Forecast (2019-2025)
Figure China Postmenopausal Vaginal Atrophy Drugs Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Japan Postmenopausal Vaginal Atrophy Drugs Production (K Units) and Growth Rate Forecast (2019-2025)
Figure Japan Postmenopausal Vaginal Atrophy Drugs Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Table Global Postmenopausal Vaginal Atrophy Drugs Consumption (K Units) Forecast by Regions (2019-2025)
Figure Global Postmenopausal Vaginal Atrophy Drugs Consumption Market Share Forecast by Regions (2019-2025)
Figure North America Postmenopausal Vaginal Atrophy Drugs Consumption (K Units) Growth Rate Forecast (2019-2025)
Figure Europe Postmenopausal Vaginal Atrophy Drugs Consumption (K Units) Growth Rate Forecast (2019-2025)
Figure China Postmenopausal Vaginal Atrophy Drugs Consumption (K Units) Growth Rate Forecast (2019-2025)
Figure Japan Postmenopausal Vaginal Atrophy Drugs Consumption (K Units) Growth Rate Forecast (2019-2025)
Table Global Postmenopausal Vaginal Atrophy Drugs Production (K Units) Forecast by Type (2019-2025)
Figure Global Postmenopausal Vaginal Atrophy Drugs Production (K Units) Forecast by Type (2019-2025)
Table Global Postmenopausal Vaginal Atrophy Drugs Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global Postmenopausal Vaginal Atrophy Drugs Revenue Market Share Forecast by Type (2019-2025)
Table Global Postmenopausal Vaginal Atrophy Drugs Price (USD/Unit) Forecast by Type (2019-2025)
Table Global Postmenopausal Vaginal Atrophy Drugs Consumption (K Units) Forecast by Application (2019-2025)
Figure Global Postmenopausal Vaginal Atrophy Drugs Consumption Forecast by Application (2019-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

 

  • Purchase Options

  • Happy To Assist You

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.

Contact us